141 related articles for article (PubMed ID: 8118931)
1. Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene.
Sisk SC; Pluta LJ; Bond JA; Recio L
Carcinogenesis; 1994 Mar; 15(3):471-7. PubMed ID: 8118931
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity and mutational spectra of 1,3-butadiene in the bone marrow of B6C3F1 lacI transgenic mice.
Recio L; Sisk S; Meyer K; Pluta L; Bond JA
Toxicology; 1996 Oct; 113(1-3):106-11. PubMed ID: 8901889
[TBL] [Abstract][Full Text] [Related]
3. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
4. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
Recio L; Pluta LJ; Meyer KG
Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
[TBL] [Abstract][Full Text] [Related]
5. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
[TBL] [Abstract][Full Text] [Related]
6. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacI transgenic mice exposed to 1,3-butadiene.
Recio L; Meyer KG
Environ Mol Mutagen; 1995; 26(1):1-8. PubMed ID: 7641703
[TBL] [Abstract][Full Text] [Related]
8. Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo.
Recio L; Bond JA; Pluta LJ; Sisk SC
IARC Sci Publ; 1993; (127):235-43. PubMed ID: 8070869
[TBL] [Abstract][Full Text] [Related]
9. In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide.
Recio L; Donner M; Abernethy D; Pluta L; Steen AM; Wong BA; James A; Preston RJ
Mutagenesis; 2004 May; 19(3):215-22. PubMed ID: 15123787
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of lacI mutants from transgenic fibroblasts exposed to 1,2-epoxybutene.
Saranko CJ; Pluta LJ; Recio L
Carcinogenesis; 1998 Nov; 19(11):1879-87. PubMed ID: 9854997
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
Meng Q; Henderson RF; Chen T; Heflich RH; Walker DM; Bauer MJ; Reilly AA; Walker VE
Mutat Res; 1999 Aug; 429(1):107-25. PubMed ID: 10434027
[TBL] [Abstract][Full Text] [Related]
15. The use of transgenic mice for studying mutagenicity induced by 1,3-butadiene.
Recio L; Goldsworthy TL
Toxicol Lett; 1995 Dec; 82-83():607-12. PubMed ID: 8597116
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
17. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity at the Hprt locus in T cells of female mice following inhalation exposures to low levels of 1,3-butadiene.
Meng Q; Henderson RF; Long L; Blair L; Walker DM; Upton PB; Swenberg JA; Walker VE
Chem Biol Interact; 2001 Jun; 135-136():343-61. PubMed ID: 11397400
[TBL] [Abstract][Full Text] [Related]
19. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T-lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats.
Meng Q; Recio L; Reilly AA; Wong BA; Bauer M; Walker VE
Carcinogenesis; 1998 Jun; 19(6):1019-27. PubMed ID: 9667740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
